Drug Information and Pharmacotherapy

DI-059

PHARMACOTHERAPEUTIC MONITORING IN GROWTH-HORMONE TREATMENT ADHERENCE

DI-057

THE CONTRIBUTION OF THE HOSPITAL PHARMACY TO THE HEALTHCARE OF PATIENTS ON ANTIRETROVIRAL THERAPY: AN IDENTIFICATION OF PATIENT NEEDS AND AN EVALUATION OF SERVICES PROVIDED

DI-056

DYSPNEA INVOLVING DIMETHYL FUMARATE: FIRST CASE REPORT

DI-055

HAEMATOLOGICAL AND CUTANEOUS ADVERSE EVENTS ASSOCIATED WITH CHRONIC HEPATITIS C TREATMENT.

DI-053

EVALUATION OF TREATMENT ADHERENCE WITH RILPIVIRINE/ EMTRICITABINE/TENOFOVIR

DI-052

ANALYSIS OF HEPATITIS B VIRUS REACTIVATION AFTER CYTOTOXIC CHEMOTHERAPY WITH RITUXIMAB

DI-050

PAMIDRONATE TREATMENT FOR HYPERCALCEMIA IN A PREMATURE NEWBORN

DI-049

DRUG INTERACTION BETWEEN LINEZOLID AND SEROTONERGIC AGONISTS: THE APPEARANCE OF SEROTONIN SYNDROME

DI-046

INTRAVITREAL BEVACIZUMAB VS LASER PHOTOCOAGULATION IN RETINOPATHY OF PREMATURITY

DI-045

SHOULD PATIENTS OF THAI, HAN CHINESE AND HONG KONG CHINESE ORIGIN BE TESTED FOR THE HLA-B*1502 ALLELE PRIOR TO PHENYTOIN TREATMENT?

DI-044

USE OF KETAMINE RINSING SOLUTION FOR REFRACTORY PAIN IN A PAEDIATRIC ONCOLOGY PATIENT: A CASE REPORT

DI-043

BIOLOGICS ARE A NEW CHALLENGE FOR HOSPITAL PHARMACISTS - PILOT STUDY OF PATIENT ADHERENCE

DI-042

ANTIBIOTIC CONSUMPTION IN PATIENTS WITH SEVERE PRESSURE ULCERS

DI-041

KETACONAZOLE: MEDICAL TREATMENT OF CUSHING'S SYNDROME

DI-040

LONG-TERM EFFECT OF AN INDIVIDUALIZED MEDICATION PLAN WITH DRUG ADMINISTRATION RECOMMENDATIONS ON THE PATIENTS' DRUG KNOWLEDGE

Pages